# Cost-Effectiveness of RSV Vaccination in U.S. Adults Aged 75â€“84  
### A Decision-Analytic and Machine Learningâ€“Enhanced Modeling Study

This repository contains a complete and reproducible cost-effectiveness analysis (CEA) of **respiratory syncytial virus (RSV) vaccination** in **U.S. adults aged 75â€“84 years**. The study combines a **Markov health economic model** with a **machine learningâ€“based risk calibration component** to evaluate both the **clinical impact** and **economic value** of RSV vaccination from a **U.S. healthcare payer perspective**.

**Final project report:** `RSV Vaccination CEA.pdf`  
**Programming language:** R  
**Methods:** Decision analysis + Machine Learning  
**Model outputs:** ICER, QALYs, CEAC, PSA

---

## Key Findings

| Outcome | Result |
|----------|--------|
| Incremental cost per person | **â€“$45.20** |
| Incremental QALYs per person | **+0.0000593** |
| ICER | **Dominant** (cost-saving + health gain) |
| Population savings (100,000 people) | **$4.52 million** |
| PSA probability cost-effective | **63â€“65%** at standard WTP thresholds |

---

## ðŸ”§ Model Overview

| Feature | Description |
|----------|-------------|
| Model type | Cohort Markov |
| Health states | Healthy (H), Outpatient RSV (O), Hospitalized RSV (I), Death (D) |
| Time horizon | 15 years |
| Perspective | U.S. healthcare payer |
| Discounting | 3% (costs & QALYs) |
| Vaccine type | Arexvy-like waning VE |
| Sensitivity | Probabilistic Sensitivity Analysis (PSA, 2,000 draws) |
| ML component | Logistic regression risk calibration |

---

## ðŸ“‚ Repository Structure

```text
â”œâ”€â”€ Dataset/                         
â”‚   â””â”€â”€ Weekly_Rates_of_Laboratory-Confirmed_RSV_Hospitalizations_from_the_RSV-NET_Surveillance_System_20251002.csv           # Raw input data
â”œâ”€â”€ Dataset_Clean/                    # Curated datasets generated during pipeline
â”‚   â”œâ”€â”€ base_incidence_age.csv
â”‚   â”œâ”€â”€ havers_structured.csv
â”‚   â”œâ”€â”€ acip_structured.csv
â”‚   â”œâ”€â”€ landi_structured.csv
â”‚   â”œâ”€â”€ ve_waning_points.csv
â”‚   â””â”€â”€ eq5d_age_util_structured.csv
â”œâ”€â”€ Figures/
â”‚   â”œâ”€â”€ ceac_plot.png
â”‚   â””â”€â”€ rsvnet_unadjusted_by_season_age.png  
â”œâ”€â”€ R/
â”‚   â”œâ”€â”€ 01_setup_packages.R
â”‚   â”œâ”€â”€ 99_helpers.R
â”‚   â””â”€â”€ Cost Effectiveness Analysis Code.R
â”œâ”€â”€ RSV Vaccination CEA.pdf         # Final manuscript report
â””â”€â”€ README.md                     
